Browse studies

Find your next paid study

138 recruiting studies matching your filters

Acquisition of Data, Blood, and Tumor Tissue Samples From Patients With Gastrointestinal Cancer

Background: \- Gastrointestinal cancers can occur in the throat, stomach, gallbladder, liver, pancreas, and colon. Researchers are interested in evaluating ho…

Non-GI CancersCancer of Gastrointestinal TractGastrointestinal Cancer

Estimated

~$10 – $675

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT01313442

Phase 3

A Phase 3, Randomized, Multicenter, Open-Label Study of Velzatinib (GSK6042981) Versus Imatinib in Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST)

Gastrointestinal Stromal Tumour (GIST) is a soft tissue tumour that develops in the digestive system, most often in the stomach or small intestine. It is cause…

Gastrointestinal Stromal Neoplasms

Estimated

~$50 – $2,250

Actual pay is set by the research site.

GlaxoSmithKlineNCT07585266

Phase 2

ctDNA-Guided Sunitinib And Regorafenib Therapy for Gastrointestinal Stromal Tumor (GIST)

The purpose of this research is to test if mutations (changes in DNA) in exons (segment of DNA or RNA containing information that has the instructions for maki…

Gastrointestinal Stromal Tumors

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of MiamiNCT05366816

Evaluation of Patients With Gastrointestinal Disease

Background: Ongoing and future research projects that study gastrointestinal diseases depend on access to biological samples and clinical data. Researchers wa…

Lower GI DiseaseGastrointestinal Diseases

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT05041374

Observational

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Mechanistic Effects of a Multi-Fiber Prebiotic Dietary Supplement (LOAM) on the Gut and Vaginal Microbiome, Gastrointestinal Well-Being, and Quality-of-Life Parameters in Women With Endometriosis and Co-Existing Gastrointestinal Symptoms

This study is a double-blind, randomized, placebo-controlled study that evaluates the safety and tolerability of a fiber-based dietary supplement and the mecha…

EndometriosisMicrobiome DysbiosisGastrointestinal Symptoms

Estimated

~$10 – $1,125

Actual pay is set by the research site.

LOAM ScienceNCT07875062

Phase 2

A Phase 2 Study to Evaluate the Efficacy and Safety of Belzutifan (MK-6482, Formerly PT2977) Monotherapy in Participants With Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Advanced Solid Tumors With HIF-2α Related Genetic Alterations

This is a study to evaluate the efficacy and safety of belzutifan monotherapy in participants with advanced pheochromocytoma/paraganglioma (PPGL), pancreatic n…

Pheochromocytoma/ParagangliomaPancreatic Neuroendocrine TumorVon Hippel-Lindau Disease+2 more

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Merck Sharp & Dohme LLC

Phase 1

A First-in-human Phase 1a/1b Study to Evaluate Safety and Tolerability of QXL138AM in Patients With Locally Advanced Un-resectable and/or Metastatic Solid Tumors and Multiple Myeloma

Study QXL138AM-001 is a Phase 1a/1b study to investigate the safety, pharmacokinetics, and preliminary activity of QXL138AM in subjects with locally advanced u…

Ovarian CancerPancreas CancerUrothelial Carcinoma+6 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Nammi Therapeutics IncNCT06582017

Phase 1

Phase 1/2, Open-Label, Multicenter, Dose Escalation and Expansion Study of BHB810 in Participants With Advanced Gastric and Gastroesophageal Junction Adenocarcinoma

This study is looking at how safe BHB810 is in adults with gastric and gastroesophageal adenocarcinoma (GEJ). The purpose of this study is also to look at: how…

Gastric CancerGastric AdenocarcinomaGastric (Stomach) Cancer+11 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Observational

Randomized Trial of Endoscopic Ultrasound Examination Using EndoSound Vision System vs. Standard Echoendoscope

This is a randomized trial to compare the standard echoendoscope with the newly developed EndoSound Visual System in the evaluation of lesions in the gastroint…

Pancreatic DiseasePancreatic CancerPancreatic Cyst+6 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Orlando Health, Inc.NCT06340620

Observational

A Randomized, Double-blind, Placebo-controlled Study Evaluating the Impact of Daily Supplementation With IgG Binding Protein LT in Support of a Healthy Gut on the Go

PS52 is a randomized, double-blind, placebo-controlled, fully decentralized study sponsored by Bactolife A/S and conducted by People Science, Inc. It evaluates…

Gut HealthGastrointestinal SymptomsSafety in Healthy Adults

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Bactolife A/SNCT07873957

Phase 1

A Phase1 b/2, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of GSK5764227 Alone and in Combination in Participants With Previously Treated Advanced Unresectable or Metastatic Gastrointestinal Solid Tumors

This study will check how well a new medicine, Risvutatug rezetecan, (Ris-Rez, also known as GSK5764227) works, how safe it is and how the body handles it in p…

Gastrointestinal Neoplasms

Estimated

~$150 – $4,500

Actual pay is set by the research site.

GlaxoSmithKlineNCT06885034

Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions

To evaluate clinical outcome for patients receiving treatment of suspected premalignant and malignant gastrointestinal lesions at Interventional Endoscopy Serv…

Gastrointestinal NeoplasmsBenign Neoplasm of Intestinal Tract

Estimated

~$10 – $750

Actual pay is set by the research site.

California Pacific Medical Center Research InstituteNCT01750619